Christopher W. Vaughan

How opioids inhibit GABA-mediated neurotransmission

M. Connor, M. Christie, C. Vaughan, 1997, Nature.

Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.

E. E. Bagley, M. Connor, M. Christie, 2000, Molecular pharmacology.

Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro

M. Christie, C. Vaughan, E. Jennings, 2001, The Journal of physiology.

Retrograde signalling by endocannabinoids.

M. Christie, C. Vaughan, Christopher W. Vaughan, 2005, Handbook of experimental pharmacology.

Opioids, NSAIDs and 5-lipoxygenase inhibitors act synergistically in brain via arachidonic acid metabolism

M. Christie, C. Vaughan, S. Ingram, 1999, Inflammation Research.

Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo‐oxygenase inhibitors in rat periaqueductal grey neurones

C. Vaughan, Christopher W. Vaughan, 1998, British journal of pharmacology.

Neurotensin inhibition of GABAergic transmission via mGluR‐induced endocannabinoid signalling in rat periaqueductal grey

H. Kawahara, C. Vaughan, V. Mitchell, 2009, The Journal of physiology.